A novel pH- and glutathione-responsive drug delivery system based on in situ growth of MOF199 on mesoporous organic silica nanoparticles targeting the hepatocellular carcinoma niche
Authors:
Open Access
- 16 October 2022
- journal article
- research article
- Published by Springer Nature in Cancer Nanotechnology
- Vol. 13 (1) , 1-21
Abstract
Background: For people with advanced hepatocellular carcinoma (HCC), systemic chemotherapy remains the only choice of palliative treatment. However, chemotherapy efficacy is not effective due to its short blood circulation times, nonspecific cell and tissue biodistribution, and rapid metabolism or excretion from the body. Therefore, a targeted nanomedicine delivery system is urgently needed. Methods: In order to improve the treatment efficiency of HCC, based on in situ growth of a copper metal organic framework on mesoporous organic silica nanoparticles, dual pH- and glutathione (GSH)-responsive multifunctional nanocomposites were synthesized as nanocarriers for enhanced HCC therapy. In this research, cellular uptake studies were performed using CLSM and Bio-TEM observations. Flow cytometry, AO-EB fluorescent staining, EdU test and Western blot were utilized to explore the apoptosis and proliferation process. In vivo imaging was employed to research the distribution of the nanocomposites in HCC tumor-bearing nude mice and the xenograft model of HCC tumor-bearing nude mice was applied to investigate the anti-tumor effects of drug-loaded nanocomposites in vivo. Results: This newly constructed degradable nanocomposite DOX/SOR@SP94 and mPEG-anchored MONs@MOF199 (D/S@SPMM) has the benefits of controllable pore size, high encapsulation efficiency, and precise targeting. According to the results of in vivo imaging and anti-tumor studies, as well as pharmacokinetic research, D/S@SPMM possessed precise HCC tumor targeting and long-lasting accumulation properties at the tumor region. Compared with traditional chemotherapy and non-targeted drug delivery systems, anti-tumor efficiency was increased by approximately 10- and 5-fold, respectively. The nanocomposites exhibited excellent anti-tumor properties without inducing observable systemic toxicity, owing to efficient DOX and SOR loading and release as well as the HCC specific targeting peptide SP94. Conclusions: The in vitro and in vivo anti-tumor results indicated that these nanocomposites could be an efficient nanomedicine for targeting HCC therapy.Keywords
Funding Information
- the Key R&D project of Science & technology Department of Sichuan Province (2020YFS0081)
- the Province Natural Science Foundation of Jiangxi Province (20202BABL216040)
- Science and Technology Bureau of Chengdu (2021-YF05-01691-SN)
This publication has 48 references indexed in Scilit:
- Molecularly organic/inorganic hybrid hollow mesoporous organosilica nanocapsules with tumor-specific biodegradability and enhanced chemotherapeutic functionalityBiomaterials, 2017
- A high-density lipoprotein-mediated drug delivery systemAdvanced Drug Delivery Reviews, 2016
- Chemistry of Mesoporous Organosilica in Nanotechnology: Molecularly Organic–Inorganic Hybridization into FrameworksAdvanced Materials, 2016
- Metal–Organic Framework‐Based Nanomedicine Platforms for Drug Delivery and Molecular ImagingSmall, 2015
- Manganese Doped Iron Oxide Theranostic Nanoparticles for Combined T1 Magnetic Resonance Imaging and Photothermal TherapyACS Applied Materials & Interfaces, 2015
- DNA Origami as an In Vivo Drug Delivery Vehicle for Cancer TherapyACS Nano, 2014
- Viral Mimicking Ternary Polyplexes: A Reduction‐Controlled Hierarchical Unpacking Vector for Gene DeliveryAdvanced Materials, 2013
- Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging CapabilitiesScience, 2012
- Cell-Specific Delivery of Diverse Cargos by Bacteriophage MS2 Virus-like ParticlesACS Nano, 2011
- Hepatocellular carcinoma cell-specific peptide ligand for targeted drug deliveryMolecular Cancer Therapeutics, 2008